Kahl-McDonagh M M, Arenas-Gamboa A M, Ficht T A
Texas A&M University, Department of Pathobiology, College Station, TX 77843-4467, USA.
Infect Immun. 2007 Oct;75(10):4923-32. doi: 10.1128/IAI.00451-07. Epub 2007 Jul 30.
Brucellosis is a zoonotic disease with a worldwide distribution that can be transmitted via intentional or accidental aerosol exposure. In order to engineer superior vaccine strains against Brucella species for use in animals as well as in humans, the possibility of challenge infection via aerosol needs to be considered to properly evaluate vaccine efficacy. In this study, we assessed the use of an aerosol chamber to infect deep lung tissue of mice to elicit systemic infections with either Brucella abortus or B. melitensis at various doses. The results reveal that B. abortus causes a chronic infection of lung tissue in BALB/c mice and peripheral organs at low doses. In contrast, B. melitensis infection diminishes more rapidly, and higher infectious doses are required to obtain infection rates in animals similar to those of B. abortus. Whether this difference translates to severity of human infection remains to be elucidated. Despite these differences, unmarked deletion mutants BADeltaasp24 and BMDeltaasp24 consistently confer superior protection to mice against homologous and heterologous aerosol challenge infection and should be considered viable candidates as vaccine strains against brucellosis.
布鲁氏菌病是一种分布于全球的人畜共患病,可通过有意或意外的气溶胶暴露传播。为了研发出更优良的针对布鲁氏菌属的疫苗株,用于动物和人类,需要考虑通过气溶胶进行攻毒感染的可能性,以便正确评估疫苗效力。在本研究中,我们评估了使用气溶胶室感染小鼠深部肺组织,以引发不同剂量的牛布鲁氏菌或羊布鲁氏菌全身感染的情况。结果显示,低剂量牛布鲁氏菌可在BALB/c小鼠的肺组织和外周器官中引起慢性感染。相比之下,羊布鲁氏菌感染消退更快,需要更高的感染剂量才能在动物中获得与牛布鲁氏菌相似的感染率。这种差异是否会转化为人类感染的严重程度仍有待阐明。尽管存在这些差异,但无标记缺失突变体BADeltaasp24和BMDeltaasp24始终能为小鼠提供针对同源和异源气溶胶攻毒感染的卓越保护,应被视为抗布鲁氏菌病疫苗株的可行候选者。